Postoperative Chemotherapy May Not Be an Optimal Multimodality Treatment Strategy for Patients with Resectable Gastric Adenocarcinoma

Authors :: H. Richard Alexander
Anthony S. Casabianca
Subir Goyal
Yong Lin
Rachel NeMoyer
David A. August
Mihir M. Shah
Jeffrey M. Switchenko
Darren R. Carpizo
Timothy J. Kennedy
Source :: Journal of the American College of Surgeons. 233:e183
Publication Year :: 2021
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2021.

Subjects :: Gastric adenocarcinoma
medicine.medical_specialty
Postoperative chemotherapy
business.industry
Multimodality Treatment
Medicine
Surgery
Radiology
business

Full Text Access

Tools